Anne Portwich

Anne Portwich is a Partner at EQT Life Sciences, based in Amsterdam, where she leads investments in medical technology, with a focus on companies developing innovative solutions that address unmet clinical needs and demonstrate strong health economic value. Anne has been with the firm for twenty-five years — she joined LSP in 2001, which became EQT Life Sciences when LSP joined forces with EQT in 2022. Over this time, she has led investment processes for numerous life sciences companies and has served on their supervisory boards. Her investments include Neuravi (Ireland), acquired by Johnson & Johnson, and Sapiens Steering Brain Stimulation (the Netherlands), acquired by Medtronic. Anne also serves on the Investment Committee of the EQT Foundation, which focuses on impact-driven investments in healthcare innovation. Anne holds an MSc in Biochemistry from the University of Hanover and a PhD from the Max Planck Institute of Marine Microbiology in Bremen. Prior to joining LSP, she worked as a Scientist and Project Leader at OctoPlus in Leiden.